| Literature DB >> 30123116 |
Melanie Spindler1,2, Katharina Koch1, Elena Borisov3, Jale Özyurt2, Peter Sörös4, Christiane Thiel2, Carsten Bantel1.
Abstract
Chronic pain (CP) is linked to changes in cognitive function. However, little is known about its influence on number sense, despite the fact that intact numerical-spatial processing is a prerequisite for valid scale-based pain assessments. This study aimed to elucidate whether number sense is changed in CP, to determine if changes have an impact on pain assessments using pain rating scales and what patient factors might contribute. N = 42 CP patients and n = 42 matched controls were analyzed (age range: 33-68 years). Numerical-spatial abilities were investigated by using number line tasks, where participants either estimated the position of a given number (position marking) or the value of a predefined mark (number naming). Pain intensity was assessed using numerical rating (NRS), verbal rating (VRS), and visual analog (VAS) scales. Additional measures included attention and working memory, verbal intelligence, medication and depression. Results revealed that in number naming, patients deviated more from expected (correct) responses than controls, and that VAS scores were significantly higher than both NRS and VRS and correlated with deviations in position making. Changes in number naming were predicted by pain intensity, sex and IQ but not by attention, memory or opioid medication. This article presents new insight on which cognitive mechanisms are influenced by CP with the focus on numerical spatial abilities. It could therefore provide useful knowledge in developing new pain assessment tools specifically for patients suffering from CP.Entities:
Keywords: chronic pain; number line task; number sense; pain assessment; pain rating scales
Year: 2018 PMID: 30123116 PMCID: PMC6085997 DOI: 10.3389/fnbeh.2018.00165
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Characteristics of participants.
| Characteristics | Controls | Chronic pain patients |
|---|---|---|
| Sample size; | 42 | 42 |
| Gender (female); | 31 (74) | 31 (74) |
| Age [years]; mean (range) | 54.1 (35–66) | 54.0 (33–68) |
| Mean education∗ ( | 2.71 (1.0) | 2.05 (1.1) |
| Verbal IQ ( | 106.0 (9.5) | 98.0 (9.3) |
| Sleeping problems | 8 | 28 |
| Duration of pain [years]; mean (range) | / | 16.8 (1–50) |
| Pain intensity∗∗ (SD) | / | 5.9 (1.6) |
| Participants on opioid medication | / | 15 |
| Participants with depression (ADS-K score > 17) | 1 | 19 |
| Handedness (right, left, retrained left-handed) | 39, 1, 2 | 37, 1, 4 |
| Fibromyalgia | / | 9 (7) |
| Musculoskeletal back pain | / | 20 (19) |
| Cervical/cervicobrachial pain | / | 7 (5) |
| Neuropathic pain | / | 3 (3) |
| Arthralgia | / | 9 (6) |
| Abdominal pain | / | 2 (2) |
| Myalgia | / | 1 (0) |
Comparisons of MADER for different experimental conditions using independent samples t-tests.
| Tasks | MADER (SD) controls | MADER (SD) patients | Cohen’s | |||
|---|---|---|---|---|---|---|
| Overall | 4.1 (1.5) | 5.1 (1.9) | -2.686 | 80 | 0.009 | 0.58 |
| Horizontal | 3.7 (1.7) | 4.2 (2.1) | -1.217 | 81 | 0.227 | 0.26 |
| Vertical | 3.7 (1.8) | 4.4 (2.0) | -1.852 | 81 | 0.068 | 0.37 |
| Horizontal | 3.8 (2.0) | 5.3 (2.4) | -3.288 | 81 | 0.001∗ | 0.60 |
| Vertical | 5.0 (2.6) | 6.1 (2.9) | -1.782 | 80 | 0.079 | 0.40 |
| Overall | 3.4 (0.9) | 4.4 (1.4) | -4.075 | 68.205 | <0.001∗ | 0.85 |
| Horizontal | 3.1 (1.3) | 4.1 (2.4) | -2.298 | 81 | 0.024 | 0.52 |
| Vertical | 3.5 (1.4) | 4.2 (1.6) | -1.987 | 81 | 0.05 | 0.47 |
| Horizontal | 3.5 (1.3) | 4.6 (2.1) | -2.813 | 81 | 0.006 | 0.63 |
| Vertical | 3.4 (1.2) | 5.0 (1.9) | -4.392 | 67.147 | <0.001∗ | 1.00 |
MADER and dependent t-statistics for low- and high-distance stimuli of the number line estimation tasks for chronic pain patients and controls.
| Number naming | Position marking | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MADER | Low distance | High distance | Low distance | High distance | ||||||
| MADER (SD) controls | 3.5 (1.2) | 3.3 (1.2) | –1.125 | 41 | 0.267 | 3.8 (1.7) | 4.3 (1.7) | 1.994 | 41 | 0.053 |
| MADER (SD) patients | 4.5 (1.6) | 4.4 (1.9) | 0.410 | 40 | 0.684 | 4.3 (1.7) | 5.8 (2.5) | 4.860 | 39 | <0.001 |
Descriptive results from the subtests of the computerized TAP battery for chronic pain patients and controls separately.
| Neuropsychological tests | Controls M (SD) | Chronic pain patients M (SD) |
|---|---|---|
| Valid trial–right target | 316.0 (63.0) | 323.0 (59.1) |
| Valid trial–left target | 322.6 (67.1) | 326.8 (67.8) |
| Invalid trial–right target | 374.2 (88.0) | 379.8 (75.8) |
| Invalid trial–left target | 352.0 (91.8) | 355.6 (72.0) |
| Omissions 0–5 min | 3.0 (2.9) | 2.9 (2.5) |
| Omissions 5–10 min | 3.0 (2.6) | 4.0 (3.6) |
| Omissions 10–15 min | 2.7 (2.5) | 3.7 (3.3) |
| Errors | 1.7 (2.0) | 2.7 (3.2) |
| Misses | 1.3 (1.6) | 1.7 (2.6) |
Overall number naming MADER regressed on different participant and pain characteristics using two stepwise regression analyses.
| Predictor | β | Standardized β | |||
|---|---|---|---|---|---|
| IQ | −0.045 | 0.013 | −0.352 | −3.422 | <0.01 |
| Group | 0.720 | 0.266 | 0.278 | 2.707 | <0.01 |
| Gender | 0.663 | 0.282 | 0.222 | 2.353 | <0.05 |
| Constant | 7.712 | 1.418 | 5.440 | <0.001 | |
| Pain intensity | 0.356 | 0.136 | 0.401 | 2.624 | <0.05 |
| Constant | 2.402 | 0.824 | 2.915 | <0.01 | |